Results 31 to 40 of about 16,252 (181)
Saudi Journal of Kidney Diseases and Transplantation, 2013 Anemia is a common concomitant disorder in dialysis patients. The responsiveness to recombinant human erythropoietin in hemodialysis (HD) patients with relative hypoparathyroidism [4 ≤ intact parathyroid hormone (iPTH) ≤16.5 pmol/L] remains undetermined.
Khalid Al Saran +2 more
doaj +1 more source
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues. [PDF]
PLoS ONE, 2015 Several clinical trials in oncology have reported increased mortality or disease progression associated with erythropoiesis-stimulating agents. One hypothesis proposes that erythropoiesis-stimulating agents directly stimulate tumor proliferation and/or ...
Scott D Patterson +7 more
doaj +1 more source
Archives of Clinical and Experimental Surgery, 2014 Background: Erythropoietin is a multifunctional cytokine, with recent studies indicating a positive effect on wound healing in models of incisional and burn wounds.
Bekka Christensen +5 more
doaj +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend Upper panel, high‐altitude training typically encompasses 3–4 weeks of altitude exposure combined with training either at altitude or at sea level. Following this, a response for haemoglobin mass (Hbmass) is seen in two of three studies, which coincides with some performance gains in <50% of studies.
Carsten Lundby, Paul Robach
wiley +1 more source
Antierythropoietin Antibodies in Hemodialysis Patients Treated with Recombinant Erythropoietin
Turkish Journal of Nephrology, 2019 OBJECTIVE: Erythropoietin resistance is a serious problem in patients treated with recombinant erythropoietin. Antierythropoietin antibodies are considered to be one of the causes of this resistance.
Savaş ÖZTÜRK +6 more
doaj
Медицинская иммунология, 2020 Our aim was to characterize anti-EPO antibodies in serum samples of the patients treated with erythropoietin. 106 serum samples from the patients treated with erythropoietin (EPO) were collected and assayed.
A. M. Kudryashova +5 more
doaj +1 more source
HUMAN RECOMBINANT ERYTHROPOIETIN GRADIENT DOSAGE INFLUENCE ON ISCHEMIC AND REPERFUSION LIVER INJURY [PDF]
Research Results in Pharmacology, 2015 We investigate influence of human recombinant erythropoietin different dosage on blood flow velocity and morphological changes in liver during ischemic and reperfusion injury. It was proved what optimal preconditioning dosage is 50 IU/kg.
Sergey Alehin +2 more
doaj +3 more sources
The Journal of Physiology, EarlyView.Abstract figure legend Pharmacologically augmenting erythropoiesis with rEPO at sea level blunts the high altitude induced erythropoiesis. Abstract Erythropoiesis increases with high altitude (HA) acclimatization. Recombinant human erythropoietin (rEPO) induces erythropoiesis.
Roy M. Salgado +15 more
wiley +1 more source
Resistance of dialyzed patients to erythropoietin
Revista Brasileira de Hematologia e Hemoterapia, 2015 Resistance to recombinant human erythropoietin is a common condition in dialyzed patients with chronic kidney disease and is associated with more hospitalizations, increased mortality and frequent blood transfusions.
Michelle Teodoro Alves +5 more
doaj +1 more source
Journal of Rawalpindi Medical College, 2021 Objective Of the Study: To compare efficacy of “Oral ascorbic acid in combination with Erythropoietin” with “standard dose of erythropoietin alone” in renal anemia in terms of mean hemoglobin rise.
Mansoor Abbas Qaiser +5 more
doaj +1 more source